Stay updated on Entrectinib in Solid Tumors Clinical Trial
Sign up to get notified when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.

Latest updates to the Entrectinib in Solid Tumors Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoChange DetectedRevision: v3.4.2 replaces v3.4.1; this seems to be a minor backend/UI update with no substantive changes to trial details, eligibility criteria, locations, or outcomes. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.0%

- Check23 days agoChange DetectedThe page now displays Revision: v3.4.1 in the footer, replacing Revision: v3.4.0. No other content or functionality of the study page appears affected.SummaryDifference0.0%

- Check37 days agoChange DetectedAdded a glossary toggle and updated the page footer to include Last Update Submitted that Met QC Criteria, Last Update Posted, and a new Revision: v3.4.0, with some label capitalization adjustments.SummaryDifference0.1%

- Check44 days agoChange DetectedAdded Revision: v3.3.4; Removed Revision: v3.3.3. No user-facing content or functionality changes observed.SummaryDifference0.0%

- Check51 days agoChange DetectedLocation data updated to add Hubei as a region and update site entries for Guangzhou (528400) and Wuhan (430023) with more complete address details. Old entries such as Guangzhou 510000 and Wuhan 430023 were removed.SummaryDifference0.2%

- Check73 days agoChange DetectedThe page's Locations section was updated with a broad list of study sites across the United States and international locations, expanding enrollment options. It also shows removals of several prior site blocks, indicating a reorganization of site listings.SummaryDifference1%

Stay in the know with updates to Entrectinib in Solid Tumors Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Entrectinib in Solid Tumors Clinical Trial page.